Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

The effects of detraining on blood adipokines and antioxidant enzyme in Korean overweight children.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • المؤلفون: Woo J;Woo J; Shin KO; Yoo JH; Park S; Kang S
  • المصدر:
    European journal of pediatrics [Eur J Pediatr] 2012 Feb; Vol. 171 (2), pp. 235-43. Date of Electronic Publication: 2011 Jun 24.
  • نوع النشر :
    Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
  • اللغة:
    English
  • معلومة اضافية
    • المصدر:
      Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7603873 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1076 (Electronic) Linking ISSN: 03406199 NLM ISO Abbreviation: Eur J Pediatr Subsets: MEDLINE
    • بيانات النشر:
      Publication: Berlin : Springer Verlag
      Original Publication: Berlin, New York, Springer-Verlag.
    • الموضوع:
    • نبذة مختصرة :
      The present study examined the change to clarify the effects of detraining on the concentration of lipid profiles, serum adipokines and antioxidant enzyme gene expression in Korean overweight children. The subjects were normal children (n = 19) and obese children (n = 20) who were further subdivided into the overweight training (OT) group (n = 10) and the overweight detraining (OD) group (n = 10). Maximal oxygen uptake (VO(2)max); body composition; lipid profiles (TG, TC); adipokines (adiponectin and leptin); antioxidants (blood and gene expressions SOD and GPX) were measured before, 12 weeks, and 24 weeks after the exercise program. Body mass index (BMI) and %fat were significantly higher in the OD group only. However, waist hip ration (WHR) and systolic blood pressure (SBP) were significantly decreased in the OT group. TG was significantly decreased in the OT group. There was a significant difference in TG level between the two groups. Besides, adiponectin was significantly increased in both the OT group and the OD group. Furthermore, leptin was significantly decreased in the OT group. There was a significant difference in leptin level between the two groups. In training groups, the expression of SOD was significantly increased after a 12- and 24-week period (p < 0.05). However, detraining group was significantly increased after a 12-week only (p < 0.05). In addition, GPX was significantly increased after a 24-week only in the training group (p < 0.05). Thus, detraining showed that negative effected on body composition and lipid profiles and maintained of uniform period on adipokines and antioxidant enzyme the protein and expression.
    • References:
      J Hepatol. 2006 Jun;44(6):1167-74. (PMID: 16618517)
      J Clin Endocrinol Metab. 2008 Nov;93(11 Suppl 1):S37-50. (PMID: 18987269)
      Biochem Pharmacol. 2000 Jan 1;59(1):1-6. (PMID: 10605928)
      Pediatr Diabetes. 2009 Jun;10(4):269-77. (PMID: 19175895)
      Circulation. 2002 Nov 26;106(22):2767-70. (PMID: 12451000)
      Circulation. 2007 Mar 20;115(11):1408-16. (PMID: 17339545)
      Clin J Sport Med. 2010 Sep;20(5):394-5. (PMID: 20818202)
      Comp Biochem Physiol C Toxicol Pharmacol. 2002 Dec;133(4):493-505. (PMID: 12458178)
      Diabetologia. 2005 Jun;48(6):1066-74. (PMID: 15864528)
      Endocr J. 2010;57(4):339-45. (PMID: 20179358)
      Circulation. 2000 Sep 12;102(11):1296-301. (PMID: 10982546)
      Circulation. 2005 Apr 19;111(15):1891-6. (PMID: 15837941)
      Scand J Med Sci Sports. 2007 Oct;17(5):595-604. (PMID: 17316373)
      Endocr J. 2003 Apr;50(2):233-8. (PMID: 12803245)
      Am J Physiol Endocrinol Metab. 2002 Oct;283(4):E861-5. (PMID: 12217905)
      J Biol Chem. 2003 Jan 24;278(4):2461-8. (PMID: 12431986)
      J Biol Chem. 2002 Jul 19;277(29):25863-6. (PMID: 12032136)
      Int J Obes (Lond). 2005 Oct;29(10):1230-5. (PMID: 15997245)
      Atherosclerosis. 2011 Apr;215(2):475-80. (PMID: 21300354)
      J Appl Physiol (1985). 2000 May;88(5):1791-6. (PMID: 10797143)
      Metabolism. 2005 Apr;54(4):482-7. (PMID: 15798955)
      Am J Hum Biol. 1999;11(2):237-247. (PMID: 11533947)
      Int J Obes Relat Metab Disord. 2003 Aug;27(8):875-88. (PMID: 12861227)
      Metabolism. 2007 Jul;56(7):1005-9. (PMID: 17570265)
      Am Heart J. 2004 Mar;147(3):489-93. (PMID: 14999199)
      Clin Endocrinol (Oxf). 1999 Mar;50(3):337-42. (PMID: 10435059)
      Taehan Kanho Hakhoe Chi. 2005 Aug;35(5):858-67. (PMID: 16208081)
      Nat Med. 2001 Aug;7(8):941-6. (PMID: 11479627)
      Am J Physiol. 1998 Feb;274(2):E280-6. (PMID: 9486159)
      J Pediatr Endocrinol Metab. 2005 Mar;18(3):303-7. (PMID: 15813609)
      Sports Med. 2000 Sep;30(3):145-54. (PMID: 10999420)
      Eur J Appl Physiol. 2010 Jul;109(5):909-14. (PMID: 20300769)
      Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1703-8. (PMID: 17895290)
      Diabetes Care. 2004 Feb;27(2):629-30. (PMID: 14747265)
      Free Radic Res. 2005 Jan;39(1):63-9. (PMID: 15875813)
      J Clin Invest. 2004 Dec;114(12):1752-61. (PMID: 15599400)
      Indian J Biochem Biophys. 2009 Apr;46(2):166-71. (PMID: 19517994)
    • الرقم المعرف:
      0 (Adiponectin)
      0 (Antioxidants)
      0 (Biomarkers)
      0 (Leptin)
      0 (Triglycerides)
      97C5T2UQ7J (Cholesterol)
      EC 1.11.1.9 (Glutathione Peroxidase)
      EC 1.15.1.1 (Superoxide Dismutase)
    • الموضوع:
      Date Created: 20110625 Date Completed: 20120911 Latest Revision: 20211020
    • الموضوع:
      20240829
    • الرقم المعرف:
      10.1007/s00431-011-1518-2
    • الرقم المعرف:
      21701811